Neuroactive drugs in growth disorders.
Ghigo
E
E
Department of Clinical Physiopathology, University of Turin, Italy.
Mazza
E
E
Bellone
J
J
Arvat
E
E
Imperiale
E
E
Procopio
M
M
Camanni
F
F
D001971:Bromocriptine / Q000008:administration & dosage / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects*; D002648:Child; D003000:Clonidine / Q000008:administration & dosage / Q000627:therapeutic use; D005188:False Negative Reactions; D006130:Growth Disorders / Q000175:diagnosis / Q000188:drug therapy*; D013006:Growth Hormone / Q000378:metabolism / Q000502:physiology; D013007:Growth Hormone-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000008:administration & dosage / Q000494:pharmacology
D001971:Bromocriptine; D007980:Levodopa; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D011729:Pyridostigmine Bromide; D003000:Clonidine